American Association for Cancer Research

New therapy for HER2-positive breast cancer developed

Patients with HER2-positive breast cancer may soon have an alternative therapy when they develop resistance to trastuzumab, also known as Herceptin, according to a laboratory finding published in Clinical Cancer Research.

Jul 26, 2011
popularity0 comments 0

Weight loss led to reduction in inflammation

Postmenopausal women who were overweight or obese and lost at least 5 percent of their body weight had a measurable reduction in markers of inflammation, according to a study published in Cancer Research, a journal of the ...

May 01, 2012
popularity0 comments 0